Document is current
Any future updates will be listed below
-
Authors
Muthumani, Karuppiah
Griffin, Bryan D
Agarwal, Sangya http://orcid.org/0000-0003-4272-515X
Kudchodkar, Sagar B
Reuschel, Emma L
Choi, Hyeree
Kraynyak, Kimberly A
Duperret, Elizabeth K
Keaton, Amelia Anne
Chung, Christopher
Kim, Yinho K
Booth, Stephanie A
Racine, Trina
Yan, Jian
Morrow, Matthew P
Jiang, Jingjing
Lee, Brian
Ramos, Stephanie
Broderick, Kate E
Reed, Charles C
Khan, Amir S
Humeau, Laurent
Ugen, Kenneth E http://orcid.org/0000-0002-7797-2049
Park, Young K
Maslow, Joel N
Sardesai, Niranjan Y
Joseph Kim, J
Kobinger, Gary P
Weiner, David B
- License Information
-
More Information
Article History
Received: 2 August 2016
Revised: 9 October 2016
Accepted: 9 October 2016
First Online: 10 November 2016
Competing interests
: D.B.W. has grant funding, participates in industry collaborations, has received speaking honoraria and fees for consulting. This service includes serving on scientific review committees and advisory boards. Remuneration includes direct payments and/or stock or stock options and in the interest of disclosure; therefore, he notes potential conflicts associated with this work with Inovio where he serves on the BOD, Merck, VGXI, OncoSec, Roche, Aldevron and possibly others. Licensing of technology from this laboratory has created over 200 jobs in the biotech/pharma industry. The remaining authors declare no conflict of interest.
